| Product Code: ETC7637379 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pharmacogenetic Testing Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Ireland Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Ireland Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Ireland Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Ireland Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Ireland Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Ireland Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Ireland Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about the benefits of pharmacogenetic testing |
4.2.2 Growing demand for personalized medicine and precision healthcare in Ireland |
4.2.3 Government initiatives supporting the adoption of pharmacogenetic testing in healthcare practices |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for pharmacogenetic testing procedures |
4.3.2 High costs associated with pharmacogenetic testing may hinder widespread adoption |
4.3.3 Lack of standardized guidelines and regulations for pharmacogenetic testing in Ireland |
5 Ireland Pharmacogenetic Testing Market Trends |
6 Ireland Pharmacogenetic Testing Market, By Types |
6.1 Ireland Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Ireland Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Ireland Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Ireland Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Ireland Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Ireland Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Ireland Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Ireland Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Ireland Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Ireland Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Ireland Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Ireland Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Ireland Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Ireland Pharmacogenetic Testing Market Export to Major Countries |
7.2 Ireland Pharmacogenetic Testing Market Imports from Major Countries |
8 Ireland Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in pharmacogenetic testing |
8.2 Adoption rate of pharmacogenetic testing in healthcare facilities |
8.3 Patient outcomes improvement rate post pharmacogenetic testing |
9 Ireland Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Ireland Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Ireland Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Ireland Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Ireland Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Ireland Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Ireland Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Ireland Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Ireland Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here